Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
Related Posts
Salesforce turns in strong results and optimistic forecast
Salesforce delivered a beat-and-raise quarter even with President Trump’s imposition of tariffs on imported goods.
Qualcomm tops estimates but gives light revenue forecast
All together, Qualcomm’s business selling chips, called QCT, rose 18% on an annual basis to $9.47 billion in revenue during the quarter.
MongoDB shares sink after company issues weak guidance
MongoDB’s earnings forecast for the 2026 fiscal year came in well below Wall Street expectations.